The research group of Prof. Pengfei Tu and Prof. Kewu Zeng has revealed the antitumor target of cucurbitacin B.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 5, p. 394
- Publication type:
- Article
Works matching IS 10031057 AND DT 2022 AND VI 31 AND IP 5
Results: 11
1
2
Triterpenoid PROTACs as a Class of Effective Hemagglutinin Protein Degraders in J. Med. Chem.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 5, p. 393
- Publication type:
- Article
3
The research group of Prof. Xinshan Ye and Prof. Decai Xiong has made new progress in stereoselective Visible-Light-Promoted glycosylation.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 5, p. 391
- Publication type:
- Article
4
Trends in innovative drug development in China was published in Nature Reviews Drug Discovery.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 5, p. 389
- Publication type:
- Article
5
Evaluation of ceftriaxone dosing regimens based on PK/PD models and Monte Carlo simulations.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 5, p. 382, doi. 10.5246/jcps.2022.05.034
- By:
- Publication type:
- Article
6
Sonogashira coupling reaction in the synthesis of novel positive allosteric modulators of α7 nicotinic acetylcholine receptors.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 5, p. 374, doi. 10.5246/jcps.2022.05.033
- By:
- Publication type:
- Article
7
Analysis of alternation with ibuprofen and acetaminophen in outpatient and emergency departments of a children's hospital.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 5, p. 369, doi. 10.5246/jcps.2022.05.032
- By:
- Publication type:
- Article
8
Fluvastatin protects against puromycin aminonucleoside-induced podocyte injury by inhibiting TRPC6.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 5, p. 360, doi. 10.5246/jcps.2022.05.031
- By:
- Publication type:
- Article
9
Network pharmacological analysis of Xiao-Xu-Ming decoction against ischemic stroke and verification of its mechanism of anti-inflammation and neurovascular protection in vivo.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 5, p. 343, doi. 10.5246/jcps.2022.05.030
- By:
- Publication type:
- Article
10
Progression of anti-mycoplasma drug therapy in children with refractory mycoplasma pneumonia.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 5, p. 334, doi. 10.5246/jcps.2022.05.029
- By:
- Publication type:
- Article
11
Matrine, oxymatrine, and compound Kushen injection from the roots of Sophora flavescens: an overview of their anticancer activities.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 5, p. 321, doi. 10.5246/jcps.2022.05.028
- By:
- Publication type:
- Article